Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates

JERUSALEM, March 08, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides, today reported financial results and key business updates for the fourth quarter and year ended December 31, 2023.

“2023 was an inflection point for Entera, with consistent validation of our disruptive N–Tab™ oral peptide technology platform and the unveiling of our goal to advance five potential first–in–class oral peptide programs, Phase 1 through Phase 3, into the clinic by the end of 2025. Each of these programs has been carefully selected to align with our platform and our mission to develop treatments that stand to become the number one choice for patients requiring peptide therapies, in a simple and convenient tablet format. Each of these programs is expected to have important catalysts during 2024. Following our December 2023 financing, we expect to have sufficient cash to fund operations through the first half of 2025,” said Miranda Toledano, CEO of Entera.

EB613: First Oral PTH(1–34) Daily Osteoanabolic Tablets for Osteoporosis

  • In March 2023, a Type D meeting between Entera and the U.S. Food and Drug Administration (FDA) re–affirmed that a placebo–controlled phase 3 study design with Bone Mineral Density (BMD) and not fracture as primary endpoint could support a New Drug Application for EB613
  • In November 2023, Entera echoed the American Society for Bone and Mineral Research (ASBMR) announcement that the Strategy to Advance BMD as a Regulatory Endpoint (SABRE) team had submitted its final qualification plan to the FDA
  • At the Annual ASBMR Meeting in October 2023, Entera presented the differentiated pharmacokinetic profile of EB613, versus Forteo® PTH(1–34) 20 µg which requires a daily subcutaneous injection. EB613 consistently shows an increased Cmax and shorter duration of systemic exposure versus Forteo®. Furthermore, EB613’s brief “pulsatile” action appears to simultaneously stimulate both a dual bone formation and a mild anti–resorptive effect, as compared to Forteo®
  • During the fourth quarter of 2023, Entera submitted its Phase 2 manuscript for potential publication in a major medical journal related to its phase 2, 6–month, 161–patient, placebo–controlled study in post–menopausal women with low bone mass and osteoporosis which met primary and secondary endpoints

“We expect an update on the qualification process of SABRE and BMD as the surrogate endpoint for fracture in 2024. We view this as the final de–risking event from a regulatory standpoint to move EB613 to Phase 3. We believe EB613 stands as the first program to potentially avail itself of the landmark SABRE initiative which is also the first biomarker to potentially be approved as part of the 2016 21st Century Cures Act. As the first potential oral tablet osteoanabolic treatment, EB613 holds the potential to address the treatment chasm in this severe, potentially lethal disease which remains significantly undertreated despite efficacious injectable treatments. Fracture rates continue to rise globally, and we have not seen any new drugs approved for osteoporosis since 2019 due to the ethical concerns and the costs of fracture endpoint studies. Our discussions with key clinicians and patient advocacy groups and other key stakeholders in this ecosystem indicate that an oral anabolic treatment is absolutely warranted and a potential ‘game changer’ for the estimated 200 million women with osteoporosis globally. We continue to hold strategic discussions related to EB613 and look forward to initiating our pivotal phase 3 study once the final qualification of the SABRE endpoint is announced by FDA,” said Miranda Toledano, CEO of Entera.

EB612: First Oral PTH(1–34) Peptide Replacement Therapy Tablets for Hypoparathyroidism
EB612, is being developed as the first oral PTH(1–34) peptide replacement treatment for hypoparathyroidism. Entera is currently evaluating its hypoparathyroidism program with an improved formulation of EB612 using the naked PTH(1–34) peptide and new intellectual property, tailored to optimize its PK profile and the potential for reduced daily dosing. Entera is also combining its N–Tab™ platform with an alternative PTH receptor agonist in a third party collaboration. Entera expects to submit data from the Phase 1 of its next generation EB612 program using the naked PTH(1–34) peptide in the first half of 2024.

First GLP–2 Peptide Tablets for Short Bowel Syndrome
Under a collaboration agreement with OPKO Health (“OPKO”), Entera is combining its N–Tab™ technology with a proprietary long–acting GLP–2 peptide for the development of the first potential daily oral GLP–2 for the treatment of short bowel syndrome and other GI disorders such as Crohn’s and Celiac disease for which GLP–2 has relevance. Entera published pre–clinical data in May 2023 demonstrating that its oral peptide delivery platform enables gastric absorption of teduglutide (Gattex®), the only approved GLP–2 treatment, as a convenient potential tablet alternative to daily injections. Pre–IND in vivo PK data for oral GLP–2 using OPKO’s long–acting analogue is expected in the first half of 2024.

First GLP–1/Glucagon Agonist (Oxyntomodulin) Peptide Tablets for Obesity
Under a collaboration agreement with OPKO, Entera is combining its N–Tab™ technology with a proprietary long–acting Oxyntomodulin (OXM) peptide for the development of the first potential daily OXM treatment for obesity and other metabolic diseases. Previously, an injectable pegylated version of this OXM peptide demonstrated significant reductions in weight loss and decreased plasma triglyceride levels with cardioprotective benefits in over 420 patients in phase 2/2B studies. Pre–IND in vivo PK data for oral OXM using OPKO’s long acting, modified analogue is expected in mid–2024.

EB613: First Oral PTH(1–34) Osteoanabolic Tablets to Treat Intense Sport and Military Stress Injuries
Entera is collaborating with leading researchers in orthopedics and sports medicine to contribute its proprietary oral PTH(1–34) tablets for an investigator sponsored Phase 2 Study seeking to treat young women and men athletes that experience stress fractures as a result of intense sports training. More details on this study are expected in the second half of 2024.

Financial Results for the year Ended December 31, 2023

As of December 31, 2023, Entera had cash and cash equivalents of $11.0 million. The Company believes that its existing cash resources will be sufficient to meet its projected operating requirements through the second quarter of 2025, which includes the capital required to fund our ongoing operations, including R&D, the completion of the Phase 1 PK study related to our new generation platform and the GLP–2/OXM collaborative research we are conducting with OPKO.

Research and development expenses for the year ended December 31, 2023 were $4.5 million, as compared to $5.8 million for the year ended December 31, 2022. The decrease of $1.3 million was primarily due to a decrease of $1.5 million in pre–clinical activity and materials costs and a decrease of $0.6 million in employee compensation, including a one–time payment made to a former employee pursuant to the terms of his separation agreement. The decrease was partially offset by an increase of $0.8 million in clinical expenses for our Phase 1 PK study related to our new generation platform and new formulations for EB612.

General and administrative expenses for the year ended December 31, 2023 were $4.4 million, compared to $7.3 million for the year ended December 31, 2022. The decrease of $2.8 million was mainly attributable to a decrease of $1.1 million in employee compensation, including a one–time payment to our former employee pursuant to the terms of his separation agreement, a decrease of $0.8 million as part of a restructuring of professional fees and other advisor expenses, a decrease in Board fees of $0.2 million due to the Board’s forfeiture of their fees for the third and fourth quarters of 2023 and a decrease of $0.7 million in D&O insurance costs.

Operating expenses for year ended December 31, 2023 were $8.9 million, as compared to $13.0 million for the year ended December 31, 2022.

Net loss was $8.9 million, or $0.31 per ordinary share (basic and diluted), for the year ended December 31, 2023, as compared to $13.1 million, or $0.45 per ordinary share (basic and diluted), for the year ended December 31, 2022.

About Entera Bio

Entera is a clinical stage company focused on developing oral peptide or protein replacement therapies for significant unmet medical needs where an oral tablet form holds the potential to transform the standard of care. The Company leverages on a disruptive and proprietary technology platform and its pipeline includes five differentiated, first–in–class oral peptide programs, expected to enter into the clinic (Phase 1 to Phase 3) by 2025. The Company’s most advanced product candidate, EB613 (oral PTH(1–34), teriparatide), is being developed as the first oral, osteoanabolic (bone building) once–daily tablet treatment for post–menopausal women with low BMD and high–risk osteoporosis, with no prior fracture. A placebo controlled, dose ranging Phase 2 study of EB613 tablets (n=161) met primary (PD/bone turnover biomarker) and secondary endpoints (BMD). Entera is preparing to initiate a Phase 3 registrational study for EB613 pursuant to the FDA’s qualification of a quantitative BMD endpoint which is expected to occur in 2024. The EB612 program is being developed as the first oral PTH(1–34) tablet peptide replacement therapy for hypoparathyroidism. Entera is also developing the first oral oxyntomodulin, a dual targeted GLP1/glucagon peptide, in tablet form for the treatment of obesity; and first oral GLP–2 peptide tablet as an injection–free alternative for patients suffering from rare malabsorption conditions such as short bowel syndrome in collaboration with OPKO Health. For more information on Entera Bio, visit www.enterabio.com or follow us on LinkedIn, Twitter, Facebook, Instagram.

Cautionary Statement Regarding Forward–Looking Statements

Various statements in this press release are “forward–looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements (other than statements of historical facts) in this press release regarding our prospects, plans, financial position, business strategy and expected financial and operational results may constitute forward–looking statements. Words such as, but not limited to, “anticipate,” “believe,” “can,” “could,” “expect,” “estimate,” “design,” “goal,” “intend,” “may,” “might,” “objective,” “plan,” “predict,” “project,” “target,” “likely,” “should,” “will,” and “would,” or the negative of these terms and similar expressions or words, identify forward–looking statements. Forward–looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties. Forward–looking statements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performance or results will be achieved.

Important factors that could cause actual results to differ materially from those reflected in Entera’s forward–looking statements include, among others: changes in the interpretation of clinical data; results of our clinical trials; the FDA’s interpretation and review of our results from and analysis of our clinical trials; unexpected changes in our ongoing and planned preclinical development and clinical trials, the timing of and our ability to make regulatory filings and obtain and maintain regulatory approvals for our product candidates; the potential disruption and delay of manufacturing supply chains; loss of available workforce resources, either by Entera or its collaboration and laboratory partners; impacts to research and development or clinical activities that Entera may be contractually obligated to provide; overall regulatory timelines; the size and growth of the potential markets for our product candidates; the scope, progress and costs of developing Entera’s product candidates; Entera’s reliance on third parties to conduct its clinical trials; Entera’s expectations regarding licensing, business transactions and strategic collaborations; Entera’s operation as a development stage company with limited operating history; Entera’s ability to continue as a going concern absent access to sources of liquidity; Entera’s ability to obtain and maintain regulatory approval for any of its product candidates; Entera’s ability to comply with Nasdaq’s minimum listing standards and other matters related to compliance with the requirements of being a public company in the United States; Entera’s intellectual property position and its ability to protect its intellectual property; and other factors that are described in the “Cautionary Statements Regarding Forward–Looking Statements,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of Entera’s most recent Annual Report on Form 10–K filed with the SEC, as well as the company’s subsequently filed Quarterly Reports on Form 10–Q and Current Reports on Form 8–K. There can be no assurance that the actual results or developments anticipated by Entera will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, Entera. Therefore, no assurance can be given that the outcomes stated or implied in such forward–looking statements and estimates will be achieved. Entera cautions investors not to rely on the forward–looking statements Entera makes in this press release. The information in this press release is provided only as of the date of this press release, and Entera undertakes no obligation to update or revise publicly any forward–looking statements, whether as a result of new information, future events or otherwise, except to the extent required by law.

 

ENTERA BIO LTD.
CONSOLIDATED BALANCE SHEETS
(U.S. dollars in thousands)
 
       
  December 31   December 31
  2023   2022
  (Unaudited)   (Audited)
   
Cash and cash equivalents 11,019   12,309
Accounts receivable and other current assets 238   540
Property and equipment, net 100   139
Other assets, net 408   139
Total assets 11,765   13,127
     
     
Accounts payable and other current liabilities 1,091   1,341
Total non–current liabilities 288   32
Total liabilities 1,379   1,373
Total shareholders' equity 10,386   11,754
Total liabilities and shareholders' equity 11,765   13,127

ENTERA BIO LTD.
CONSOLIDATED STATEMENTS OF OPERATIONS
(U.S. dollars in thousands, except share and per share data)
 
(Unaudited)
 
  Year Ended
December 31,
  2023   2022
       
REVENUES   134
COST OF REVENUES   101
GROSS PROFIT   33
OPERATING EXPENSES:      
Research and development 4,510   5,848
General and administrative 4,430   7,253
Other income (49)   (51)
TOTAL OPERATING EXPENSES 8,891   13,050
OPERATING LOSS 8,891   13,017
FINANCIAL INCOME, NET (31)   (83)
LOSS BEFORE INCOME TAX 8,860   12,934
INCOME TAX EXPENSES 29   137
NET LOSS 8,889   13,071
       
BASIC AND DILUTED LOSS PER SHARE 0.31   0.45
WEIGHTED AVERAGE NUMBER OF SHARES      
OUTSTANDING USED IN COMPUTATION OF 29,007,794   28,808,090
BASIC AND DILUTED LOSS PER SHARE      


GLOBENEWSWIRE (Distribution ID 9060543)

St Kitts and Nevis Paves the Way for its Global Citizens to “Connect, Collaborate and Celebrate” at the Investment Gateway Summit

Basseterre, March 08, 2024 (GLOBE NEWSWIRE) — The Government of St Kitts and Nevis have ushered in a new era of investing through the “Investment Gateway Summit”, calling for its economic citizens to visit their home. Global investors and high–net–worth individuals (HWNIs) can explore endless opportunities whilst being hosted by the Government. 

The Prime Minister of St Kitts and Nevis, Honourable Dr. Terrance Drew, along with his Government, extends a personal invitation to citizens and investors to attend the exclusive inaugural Investment Gateway Summit from 11 to 15 May 2024.  

This significant event is an opportunity for Kittian and Nevisian citizens around the world to return home to discover how the twin–island federation is utilising economic diversification to advance developments and our citizens. 

This personal invitation from Honourable Dr. Drew, is an experience not to be missed to learn about the Sustainable Island State Agenda from the Government and key speakers , while connecting and building with visionary leaders, global businesspeople, and economic citizens. 

During the five–day Summit, economic citizens can engage and interact with national leaders and global experts. They can also explore the natural wonders the islands have to offer, with unique premium experiences to share with the world. 

Please click here to secure your exclusive spot at the Investment Gateway Summit. 

What to Expect from the Summit? 

As an economic citizen, this will be your opportunity to connect with like–minded individuals in various businesses and network with businesspeople. 

Economic Citizens will have the opportunity to experience firsthand what initiatives St Kitts and Nevis are engaging in and the progress of each development. 

Learn about St Kitts and Nevis’ economic outlook for 2024 and beyond in addition to understanding how economic diversification can inspire change. Investment–led projects in the twin–federation and how you can become part of these exciting developments will be presented. 

Gain insights into the Sustainable Island State Agenda and why it is an essential element in the “Investment Gateway Summit” in May 2024. 

The Sustainable Island State Agenda key focus is on seven pillars: 

1. Food security 

2. Green energy transition 

3. Economic diversification 

4. Developing the Creative Economy 

5. Post–pandemic recovery 

6. Attract and support sustainable organisations 

7. Extend social protection and safety for vulnerable individuals 

These seven pillars form part of the Sustainable Island State Contribution (SISC), which is an exciting new investment option under the Citizenship by Investment (CBI) Programme

The SISC is an opportunity to contribute to the development of a new nation. It's a secure and sustainable option for savvy investors looking to make a strategic investment. 

Collaborative sustainable development initiatives will nurture economic and community development and extend shared values of excellence. 

“Connect, Collaborate and Celebrate” with Us 

If you're interested in promoting your brand, business services, or exploring sponsorship opportunities, feel free to leave a comment here along with your inquiry in the contact form. We'll promptly respond with details on available packages. 

Tickets are limited – make sure to get your early bird tickets! 

Attachment


GLOBENEWSWIRE (Distribution ID 9060634)

Unveiling Blind Spots & Critical Insights to Fight Poverty Effectively

Credit: WFP/Arete/Siegfried Modola

By Olivier De Schutter and Luis Felipe López-Calva
WASHINGTON DC, Mar 8 2024 – Poverty is multidimensional. If we think of classical thinkers, Adam Smith referred to the basis of self-respect and the importance of being able to “appear in public without shame,” while John Rawls wrote about “primary goods,” which included rights and liberties as well as income and wealth.

Amartya Sen, advancing in formalization, brought the notion of “functionings” as the “beings and doings” effectively available to people in their capability set, so they can “pursue the life plans they have reasons to value.”

It is mainstream today to argue that poverty is multidimensional, moving beyond just access to goods and services. But exploring which dimensions are “appropriate” in each context has been a fundamental pursuit of development analysts and practitioners in recent decades.

It has been almost 30 years since Sabina Alkire devoted her work to the understanding, classification, and measurement of the many dimensions of poverty, particularly those that are “hidden” in our concepts and indicators.

Indeed, there are some dimensions associated with experiencing the condition of poverty that cannot be so easily observed and have not been properly measured yet are very important when it comes to policy effectiveness.

Those dimensions include aspects related to emotions that trigger behavioural responses: feelings of isolation, discrimination, effects on the sense of dignity and self-respect, and disempowerment. We have come a long way in our thinking about poverty, but our actions to tackle it and to understand the complex interactions between dimensions remains underdeveloped.

At the World Bank, the project on “Voices of the Poor,” started almost 30 years ago, strove to think differently about poverty. It drew on the views of 60,000 people living in poverty across 60 countries to better understand the challenges they faced, helping expand our understanding of poverty to include not only income and consumption but also lack of access to education and health, powerlessness, voicelessness, vulnerability, and fear.

Later, in 2012, the Social Observatory project used a broader view of poverty dimensions to make anti-poverty projects more adaptive—and ultimately more effective. Since 2018, the World Bank’s multidimensional poverty measure has gone beyond monetary deprivation to include other dimensions such as access to education, health, nutritional, and basic infrastructure services.

And in 2023, the World Bank began publishing the multidimensional poverty index—an effort by the Oxford Poverty and Human Development Initiative and the United Nations Development Programme—which is especially pertinent for low-income countries.

More recently, researchers from the University of Oxford and the global anti-poverty movement ATD Fourth World uncovered a set of “hidden dimensions of poverty” through a three-year participatory research project in six countries (Bangladesh, Bolivia, France, Tanzania, the United Kingdom, and the United States) that sought to further refine our understanding of poverty.

The teams identified nine dimensions of poverty that were common across all countries, despite the vastly different circumstances in each, using the “merging of knowledge” methodology. This approach brings together people in poverty (with their knowledge of the reality of poverty), academics (with their scientific knowledge), and practitioners (with their action-based knowledge).

The identified dimensions included a lack of decent work or income, of course, but also feelings of powerlessness, lacking control, and experiencing “povertyism” (negative attitudes and behaviours toward people living in poverty).

These lesser-recognized and lesser-visible dimensions of poverty are no less important for policies designed to combat poverty than a person’s income or access to employment. Escaping poverty will be far more difficult if you don’t also address the discrimination people in poverty face, the shame they experience, or the “aspirations gap” that results from being raised in a low-income household.

But until now, policy makers have lacked the practical tools they need to properly capture and combat these hidden, and thus largely ignored, dimensions of poverty.

The Inclusive and Deliberative Elaboration and Evaluation of Policies (IDEEP) tool, which was presented at the ATD Fourth World, International Monetary Fund, and World Bank conference on Addressing the Hidden Dimensions of Poverty in Knowledge and Policies, is the first of its kind to help policy makers transform the findings of this research into action.

Created in partnership between the UN Special Rapporteur on extreme poverty and human rights and ATD Fourth World, the IDEEP tool supports policy makers in designing, implementing, and evaluating anti-poverty policies in direct partnership with people in poverty, ensuring all its dimensions, including those that are “hidden,” are taken into account.

This is crucial, given that policies that do not account for the views and lived experiences of people in poverty tend to be riddled with blind spots, particularly around these hidden dimensions.

The IDEEP tool identified social isolation among disadvantaged communities as an unintended result of a housing project in Mauritius, for example, and institutional maltreatment resulting in fewer people accessing social protection benefits in France.

The right to participation is a human right. Only by upholding it will we achieve better informed, more effective, and more imaginative policy making. Yet the record of participatory processes in anti-poverty policy making is mixed, with policy makers often simply “informing” or “consulting” people in poverty, rather than recognizing them as the real experts about the obstacles they face.

To combat this, we need to go one step further in our efforts to fulfil the right to participation by introducing the idea of “deliberation,” which is defined in the IDEEP tool as bringing together different groups, including people in poverty, who meet, present arguments based on their unique insights, weigh them up, and propose actionable solutions.

The IDEEP tool offers a new, deliberative approach to anti-poverty policy making, one that recognizes the power imbalances inherent in traditional participatory processes and brings together different groups as equals to debate potential solutions before arriving at a consensus. This is a true merging of knowledge.

This approach is especially urgent as we rapidly head towards 2030, the target year for achievement of the Sustainable Development Goals (SDGs), including the goal of eradicating extreme poverty for all people everywhere (SDG1). If we continue on a path of business as usual, we will not achieve this ambitious goal.

We need to widen our perspective and rethink how we can jumpstart a process of inclusive and sustainable growth for all; this includes engaging with those with lived experiences in poverty in the search for meaningful, holistic policy solutions. Without embracing this, efforts to combat poverty—and its hidden dimensions—will fall flat.

Olivier De Schutter is UN Special Rapporteur on extreme poverty and human rights, Human Rights Council; Luis Felipe Lopez-Calva is Global Director, Poverty and Equity Global Practice.

Source: World Bank

IPS UN Bureau

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

Alarming Increase in Journalists Killed in Conflict Zones Last Year, says UNESCO

Credit: UNESCO

By Thalif Deen
UNITED NATIONS, Mar 8 2024 – The Paris-based UN Educational, Scientific and Cultural Organization (UNESCO), whose mandate includes promoting the safety of journalists and ensuring press freedom worldwide, has pointed out that 2023 has been a particularly deadly year for journalists who work in conflict zones.

Audrey Azoulay, UNESCO Director-General, said at least 38 journalists and media workers were killed in the line of work in countries in conflict in 2023, compared to 28 in 2022 and 20 in 2021.

The ongoing hostilities in the Middle East were responsible for a large majority of conflict-related killings, with UNESCO having so far reported 19 killings in Palestine, 3 in Lebanon and 2 in Israel since 7 October.

The killings of journalists also took place in conflict zones and civil wars in Afghanistan, Cameroon, Syria and Ukraine.

“This is a dramatic toll. Never in a recent conflict has the profession had to pay such a heavy price in such a short space of time”.

“I call on regional and international actors to take immediate action to ensure that international law is respected. Journalists should never, under any circumstances, be targeted. And it is the responsibility of all actors to ensure that they can continue to exercise their profession safely and independently,” she said.

Jodie Ginsberg, CEO of Committee to Protect Journalists (CPJ), told IPS “the near-record high number of journalist killings in 2023 clearly indicates that we must work collectively to ensure that journalist killers are brought to justice, that a culture of safety prevails in newsrooms, and that the public’s right to be informed is protected from those whose power is threatened by the scrutiny of reporting.”

UNESCO said the figures do not include deaths of journalists and media workers in circumstances unrelated to their profession, which have also been reported in significant numbers in 2023.

And these tragedies are only the tip of the iceberg, with widespread damage and destruction of media infrastructure and offices and many other kinds of threats such as physical attack, detention, the confiscation of equipment or denial of access to reporting sites. Large numbers of journalists have also fled or stopped working.

Such a climate contributes to what UNESCO is describing as “zones of silence” opening up in many conflict zones, with severe consequences for access to information, both for local populations and the world at large.

This global trend can be explained by a significant decline in killings outside of conflict zones, which have reached their lowest total for at least fifteen years – especially in Latin America and the Caribbean, where 15 killings were reported, compared with 43 in 2022, according to UNESCO.

In a March 7 report, CPJ provided its most recent and preliminary account of journalist deaths in the war. “Our database will not include all of these casualties until we have completed further investigations into the circumstances surrounding them.”

“The Israel-Gaza war has taken a severe toll on journalists since Hamas launched its unprecedented attack against Israel on October 7 and Israel declared war on the militant Palestinian group, launching strikes on the blockaded Gaza Strip”.

CPJ said it is investigating all reports of journalists and media workers killed, injured, or missing in the war, which has led to the deadliest period for journalists since CPJ began gathering data in 1992.

As of March 7, CPJ’s preliminary investigations showed at least 95 journalists and media workers – higher than the UNESCO figures– were among the more than 31,000 killed since the war began on October 7—with more than 30,000 Palestinian deaths in Gaza and the West Bank and 1,200 deaths in Israel.

The Israel Defense Forces (IDF) told Reuters and Agence France Press news agencies last October that it could not guarantee the safety of their journalists operating in the Gaza Strip, after they had sought assurances that their journalists would not be targeted by Israeli strikes, according to a Reuters report.

Journalists in Gaza face particularly high risks as they try to cover the conflict during the Israeli ground assault, including devastating Israeli airstrikes, disrupted communications, supply shortages, and extensive power outages.

CPJ said reporting from the front lines of a conflict is one of the most challenging assignments a journalist can undertake.

“It is important that journalists prepare before an assignment to understand the environment they are entering –and the deadly threats they may face”.

Striking a more personal note, the CPJ said it is deeply saddened by the killing of Al-Jazeera Arabic camera operator Samer Abu Daqqa and the injuries suffered by his colleague, Al-Jazeera Gaza bureau chief Wael Dahdouh who was injured in what was believed to be an Israeli drone strike in Khan Yunis, southern Gaza, on December 15.

The CPJ called on international authorities to conduct an independent investigation into the attack to hold the perpetrators to account.

The wife, son, daughter and grandson of Wael Dahdouh, were also killed in an Israeli air raid.

IPS UN Bureau Report

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

WTA Foundation and Gates Foundation launch new campaign—Women Change the Game—to urge action on women’s health and nutrition

St. Petersburg, Fla. and Seattle, March 08, 2024 (GLOBE NEWSWIRE) — Today, on International Women’s Day, the WTA Foundation and the Bill & Melinda Gates Foundation unveiled Women Change the Game, a new campaign uniting the power of women’s tennis and philanthropy to elevate women’s health and nutrition as a global priority. A key component of the campaign is the first–of–its–kind WTA Foundation Global Women’s Health Fund. With an inaugural donation from WTA Tour title sponsor Hologic, in its first year, the Fund will focus on a key aspect of preventive care: It aims to support at least one million women with prenatal vitamins in low– and middle–income countries where access to adequate nutrition for maternal health is limited.

“Throughout my life, tennis has given me a pathway to pursue my dreams, and I know first–hand how important it is to have access to the right health care and nutrition,” said Caroline Wozniacki, former WTA World No. 1 champion, and mother of two. “On International Women’s Day and beyond, I am proud to shine a light on women’s health and nutrition in the hopes that all women can reach their full power and potential.”

Women spend 25% more of their life in poor health than men, according to a 2024 report by the World Economic Forum. This significant health gap impacts women’s quality of life and limits their ability to engage in the workforce and earn a living for themselves and their families. And in the face of global crises—humanitarian disasters, war, and climate change—women and girls suffer the worst consequences.

“Every woman and girl deserves an equal opportunity to be her best—whether in school, at work, or on the tennis court,” said Naomi Osaka, four–time Grand Slam singles champion and new mom. “We are stepping up for women in need, because when we champion each other, we all win.”

Today, more than 1 billion women and girls lack access to the good nutrition and healthy diets they need to survive and thrive, with dire consequences for themselves and their children. Across the world, the gender nutrition gap is worsening. Women and girls are 50% more likely to suffer from malnutrition than boys and men. While the majority of expectant mothers in high–income countries take prenatal vitamins throughout their pregnancies, most women in low– and middle–income countries lack access to this simple, lifesaving resource. Prenatal vitamins provide key nutrients that dramatically reduce the risk of stillbirth, infant mortality, and babies born small and vulnerable, and they improve women’s health.

“It is unacceptable that so many women and girls don’t have access to adequate nutrition and basic care,” said Melinda French Gates, co–chair of the Bill & Melinda Gates Foundation. “The WTA Foundation was founded on the idea of equal opportunity, and that’s exactly what Women Change the Game is about. Nowhere is it more important to level the playing field than women’s health.”

Women Change the Game
Women Change the Game will engage global audiences through tennis—translating the power of elite athletes on the court into elite influence off the court—to take on some of the most pressing and urgent issues for women and girls. A critical component of the campaign is the new WTA Foundation Global Women’s Health Fund, which will mobilize resources for lifesaving women’s health and nutrition products and services that are readily available in high–income countries but are difficult to access or altogether unavailable in low– and middle–income countries.

The campaign features creative assets, including video, digital, and social content, that elevate the voices of elite women athletes in service of women’s equality and better health and nutrition for women worldwide. A series of activations across the Hologic WTA Tour will engage corporate sponsors, tournaments, philanthropic partners, athletes, and fans to raise awareness and funding for women’s health and nutrition. The campaign drives audiences to womenchangethegame.com to engage on the issues and donate.

The WTA Foundation Global Women’s Health Fund
The fundraising component of the partnership is the Global Women’s Health Fund, with the kick–off donation of $1.5 million coming from Hologic, title sponsor of the WTA Tour and one of the world’s top medical technology innovators focused on improving women’s health and well–being. Collaboration on the Fund marks the latest expansion of the WTA’s and Hologic’s comprehensive, multiyear alliance to elevate women’s well–being. The Fund leverages data insights from sources like the Hologic Global Women’s Health Index, which shows the interlocking importance of preventive care, access to adequate food and shelter, strong educational opportunities, and other critical resources for women and girls of all ages.

“Whether it’s prenatal vitamins for expectant mothers or routine screenings for breast and cervical cancers, we know that early intervention is pivotal to helping women live longer and better,” said Stephen P. MacMillan, chairman, president, and CEO of Hologic. “As the first donor to the Global Women’s Health Fund, we’re teaming up with the WTA Foundation and the Bill & Melinda Gates Foundation in urging others—businesses, foundations, governments, tennis fans—to join us in this crucial movement of improving women’s health.”

For at least the first year, every dollar raised through the Fund will be directed toward the Child Nutrition Fund, a global initiative aimed at ending child wasting led by UNICEF, with support from the U.K. government, the Children’s Investment Fund Foundation, the Bill & Melinda Gates Foundation, and other partners. UNICEF, a leader in global health and nutrition, has the worldwide footprint and local partnerships necessary to bring products and services directly into the hands of women in need around the world.

For more information about Women Change the Game and the WTA Foundation’s Global Women’s Health Fund, visit www.womenchangethegame.com.

About the WTA
Founded by Billie Jean King in 1973 on the principle of equal opportunity, the WTA is the global leader in women’s professional sports. The WTA is one of the world’s most recognizable and high–profile sports organizations, consisting of more than 1,600 players representing over 80 nations, all competing to earn WTA rankings points and prestigious tournament titles. The Hologic WTA Tour is comprised of over 70 events and four Grand Slams, spanning 30 countries and regions across six continents with a global audience of more than 1 billion. Further information on the WTA can be found at wtatennis.com.

About the WTA Foundation
Serving as the philanthropic arm of the leading women’s professional sport globally, the WTA Foundation empowers girls and women to live fully and supports our WTA communities worldwide through initiatives promoting equality, education, leadership, and health and wellness.

About the Bill & Melinda Gates Foundation
Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Mark Suzman, under the direction of Co–chairs Bill Gates and Melinda French Gates and the board of trustees.

Attachments


GLOBENEWSWIRE (Distribution ID 9060346)

International Women’s Day, 2024Inside Women Dominated Seaweed Farms in Kenya’s Indian Ocean Waters

Seaweed farming using the off-bottom seaweed farming approach—tying algal fonds or seaweed seeds to ropes attached between wooden pegs driven into the ocean sediment. Credit: Joyce Chimbi/IPS

Seaweed farming using the off-bottom seaweed farming approach—tying algal fonds or seaweed seeds to ropes attached between wooden pegs driven into the ocean sediment. Credit: Joyce Chimbi/IPS

By Joyce Chimbi
MWAZARO BEACH, Kenya, Mar 8 2024 – Nearly two kilometers into the Indian Ocean from the Mwazaro beach coastline in Lunga Lunga Sub-County, Kwale County, women can be spotted seated in the shallow ocean waters or tying strings to erected poles parallel to the waves. It is a captivating sight to see rows of seaweed farms in the Indian Ocean.

Seaweeds are a group of algae found in seawater and come in green, red, and brown species. The seaweed farms are a predominantly female-dominated form of aquaculture and their owners can only be spotted during low tide, especially in the morning. Once the tide comes in, the women will begin their journey back to the shores as the waters slowly rise.

Saumu Hamadi tells IPS that in 2016, residents of Mwambao village along the Mwazaro beach coastline started a community-led, community-driven initiative to conserve mangroves, protect the environment, and restore their fisheries, which had been destroyed by significant mangrove forest degradation.

“We realized that the more our mangroves disappeared, the fish ran away and so did the fishermen. We rely on fish for food and money. Men sell the big fish, such as the kingfish, shark, and rayfish, to the beach hotels, and women sell crabs and prawns by the roadside or in small village markets. The situation was threatening our daily bread and we decided to volunteer as a community to restore and protect our mangroves,” Hamadi explains.

Rehema Abdalla walking to her seaweed farm, located nearly 1.7 km away from Mwazaro Beach coastline. Seaward farming is conducted in the ocean during low tides. Credit: Joyce Chimbi/IPS

Rehema Abdalla walking to her seaweed farm, located nearly 1.7 km away from the Mwazaro Beach coastline. Seaward farming is conducted in the ocean during low tides. Credit: Joyce Chimbi/IPS

 

Rehema Abdalla and Saumu Hamadi walking to their seaweed farms, where other women are already hard at work, sorting and packing their harvests. Credit: Joyce Chimbi/IPS

Rehema Abdalla and Saumu Hamadi walking to their seaweed farms, where other women are already hard at work, sorting and packing their harvests. Credit: Joyce Chimbi/IPS

 

Rehema Abdalla and Saumu Hamadi weigh seaweed using a home scale. Credit: Joyce Chimbi/IPS

Rehema Abdalla and Saumu Hamadi weigh seaweed using a home scale. Credit: Joyce Chimbi/IPS

 

Women at work at the seaweed farm. Credit: Joyce Chimbi/IPS

“There were too many people cutting down mangrove trees, destroying the places that the fish we depend on call home. There was also a lot of soil erosion and the water flowing along the River Hamisi that pours into the Indian Ocean within this village’s coastline carried the soil into the ocean, polluting it. We formed two community groups: Mwambao Mkuyuni Youth and Bati Beach Mwambao. Women make up 80 percent of the members in both groups.”

Abdalla Bidii Lewa, a community coordinator on mangrove restoration in Pongwe Kikoneni ward where Mwambao village is located and chair of Bati Seaweed Farmers, tells IPS, “Mangroves have protected our villages and surrounding areas from extreme weather and disasters such as those that affected large parts of the coastal region during the heavy floods in November and early December 2023. Where houses were swept away and farmlands destroyed, we were safe from the disaster.”

Seaweed farming.Credit: Joyce Chimbi and Cecilia Russell/IPS

Seaweed farming. Credit: Joyce Chimbi and Cecilia Russell/IPS

Research shows mangroves significantly prevent the progression of climate change while also playing a major role in limiting its impact. This is critical as temperatures rise dangerously, sea level shoots to alarming levels, and coastal climate-induced disasters become frequent, intense, and severe, with catastrophic results.

To avert coastal climate hazards and secure mangrove-related benefits for present and future generations, the community undertook mangrove conservation and restoration activities in earnest.

Then, in 2017, a scientist conducting research into seaweed farming using the off-bottom seaweed farming method—tying algal fonds or seaweed seeds to ropes attached between wooden pegs driven into the ocean sediment—approached women in the community.

“Of the two seaweed strains that grow on Kenya’s south coast, cottonii and spinosum, the scientist recommended that we plant spinosum and gave us the seeds. Seaweeds do not need something to grow on. We erect sticks into the ground inside the ocean water during low tides and plant seaweed seeds by tying them to strings fastened on these sticks. We harvest every 45 days. We have to tie the strings and place the sticks properly so that they are not swept away during high tides,” says Rehema Abdalla, a seaweed farmer in Mwambao village.

On concerns that aquaculture could form the entry point for mangrove degradation, Hamadi says, “It is not the case with seaweed. The mangroves are important to the survival of our seaweeds by ensuring that we have normal, safe tides and waves. When seaweeds are swept away, they stay trapped within the roots of the mangroves and we collect them from there. It is rare, but once in a while, the tides can be very strong.”

Lewa says seaweed farming is emerging as a new and sustainable climate change mitigation strategy while offering communities adjacent to mangroves and coastlines an alternative livelihood, reducing dependency on fishing and natural resources inside mangrove forests and the oceans. Seaweeds are superfoods, highly nutritious, can be used in sushi, soups, salads, and smoothies, and are an asset in the feed industry, cosmetics, and pharmaceuticals.

“The amount of seaweed harvested depends on the amount planted and every 45 days, you will get a harvest. At the moment, one kilogram of seaweed goes for USD 0.22 (Ksh 35). I am currently targeting making USD 467 (Ksh 75,000) every 45 days from seaweed. We also sell seaweed seeds to other women doing mangrove conservation, such as Imani Gazi and the Gazi Women Mangrove Restoration Group, from within Kwale County,” Hamadi says.

Seaweeds compliment mangroves by absorbing nutrients such as nitrogen, phosphorous, and carbon dioxide. They do not require soil, fertilizer, freshwater, or pesticides, and they significantly improve the environment in which they grow. Seaweeds efficiently absorb carbon dioxide, using it to grow and even when harvested, the carbon remains in the ocean.

Research shows that seaweed can pull more greenhouse gases from the water compared to seagrass, salt marshes, and mangroves based on biomass. Mwazaro’s beach community is on track to add seaweed as part of their blue carbon sink, setting the pace for other coastal communities.

All the same, the women are facing challenges such as a lack of mortar boats to help transport their harvest to the shore. Currently, they use a tedious process whereby they tie sacks of seaweed on their waste and wait for the onset of high tide in the early afternoon to push them from the seaweed farms to the shore. They are also struggling to access a larger market, currently relying on one major large-scale buyer and small buyers within the village and other mangrove conservation groups from neighboring villages.

IPS UN Bureau Report

This feature is published with the support of Open Society Foundations.


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);